These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10996030)

  • 1. Prevention of collagen-induced arthritis in DBA/1 mice by oral administration of AZ-9, a bacterial polysaccharide from Klebsiella oxytoca.
    Sugihara R; Yoshimura M; Mori M; Kanayama N; Hikida M; Ohmori H
    Immunopharmacology; 2000 Sep; 49(3):325-33. PubMed ID: 10996030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment with an anti-IL-4 monoclonal antibody blocks suppression of collagen-induced arthritis in mice by oral administration of type II collagen.
    Yoshino S
    J Immunol; 1998 Mar; 160(6):3067-71. PubMed ID: 9510213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intranasal administration of denatured type II collagen and its fragments can delay the onset of collagen-induced arthritis.
    Matsumoto T; Ametani A; Hachimura S; Iwaya A; Taguchi Y; Fujita K; Shigehisa T; Kaminogawa S
    Clin Immunol Immunopathol; 1998 Jul; 88(1):70-9. PubMed ID: 9683552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-12 promotes cellular but not humoral type II collagen-specific Th 1-type responses in C57BL/6 and B10.Q mice and fails to induce arthritis.
    Szeliga J; Hess H; Rüde E; Schmitt E; Germann T
    Int Immunol; 1996 Aug; 8(8):1221-7. PubMed ID: 8918691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of nasal and oral tolerance for the prevention of collagen induced murine arthritis.
    Higuchi K; Kweon MN; Fujihashi K; McGhee JR; Kiyono H
    J Rheumatol; 2000 Apr; 27(4):1038-44. PubMed ID: 10782834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential activities of immunogenic collagen type II peptides in the induction of nasal tolerance to collagen-induced arthritis.
    Chu CQ; Londei M
    J Autoimmun; 1999 Feb; 12(1):35-42. PubMed ID: 10028020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppressive effects of the oral administration of Lactobacillus casei on type II collagen-induced arthritis in DBA/1 mice.
    Kato I; Endo-Tanaka K; Yokokura T
    Life Sci; 1998; 63(8):635-44. PubMed ID: 9718093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of IL-10-producing CD4+CD25+ T cells in animal model of collagen-induced arthritis by oral administration of type II collagen.
    Min SY; Hwang SY; Park KS; Lee JS; Lee KE; Kim KW; Jung YO; Koh HJ; Do JH; Kim H; Kim HY
    Arthritis Res Ther; 2004; 6(3):R213-9. PubMed ID: 15142267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of collagen induced arthritis in mice utilizing plasmid DNA encoding interleukin 10.
    Miyata M; Sasajima T; Sato H; Saito A; Saito A; Iriswa A; Sato Y; Kasukawa R
    J Rheumatol; 2000 Jul; 27(7):1601-5. PubMed ID: 10914840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastric administration of recombinant 65 kDa heat shock protein delays the severity of type II collagen induced arthritis in mice.
    Jorgensen C; Gedon E; Jaquet C; Sany J
    J Rheumatol; 1998 Apr; 25(4):763-7. PubMed ID: 9558182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potent adjuvant effect by anti-CD40 in collagen-induced arthritis. Enhanced disease is accompanied by increased production of collagen type-II reactive IgG2a and IFN-gamma.
    Tellander AC; Michaëlsson E; Brunmark C; Andersson M
    J Autoimmun; 2000 Jun; 14(4):295-302. PubMed ID: 10882055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Inhibitory effects of portal venous injection of type II collagen in collagen-induced arthritis].
    Ogasawara H; Watari E; Shirai Y; Yokomuro K
    Nihon Ika Daigaku Zasshi; 1997 Jun; 64(3):220-4. PubMed ID: 9217364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolerance induction by a poorly arthritogenic collagen II can prevent collagen-induced arthritis.
    van Vollenhoven RF; Nagler-Anderson C; Soriano A; Siskind GW; Thorbecke GJ
    Cell Immunol; 1988 Aug; 115(1):146-55. PubMed ID: 3401929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
    Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppressive effect of hochu-ekki-to on collagen induced arthritis in DBA1J mice.
    Hai le X; Kogure T; Niizawa A; Fujinaga H; Sakakibara I; Shimada Y; Watanabe H; Terasawa K
    J Rheumatol; 2002 Aug; 29(8):1601-8. PubMed ID: 12180716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The preventive effect of oral administration of type I interferon on collagen-induced arthritis in rats.
    Yoshino S
    Exp Mol Pathol; 1995 Apr; 62(2):123-30. PubMed ID: 8549696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of murine collagen-induced arthritis by nasal administration of collagen.
    Myers LK; Seyer JM; Stuart JM; Kang AH
    Immunology; 1997 Feb; 90(2):161-4. PubMed ID: 9135541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD28-deficient mice are highly resistant to collagen-induced arthritis.
    Tada Y; Nagasawa K; Ho A; Morito F; Ushiyama O; Suzuki N; Ohta H; Mak TW
    J Immunol; 1999 Jan; 162(1):203-8. PubMed ID: 9886387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced susceptibility to collagen-induced arthritis in mice deficient in IFN-gamma receptor.
    Kageyama Y; Koide Y; Yoshida A; Uchijima M; Arai T; Miyamoto S; Ozeki T; Hiyoshi M; Kushida K; Inoue T
    J Immunol; 1998 Aug; 161(3):1542-8. PubMed ID: 9686622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a peptide analog of a determinant of type II collagen that suppresses collagen-induced arthritis.
    Myers LK; Tang B; Rosloniec EF; Stuart JM; Chiang TM; Kang AH
    J Immunol; 1998 Oct; 161(7):3589-95. PubMed ID: 9759881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.